✦ LIBER ✦

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma

✍ Scribed by Naoe Goto; Hisashi Tsurumi; Masao Takemura; Takeshi Hara; Michio Sawada; Senji Kasahara; Nobuhiro Kanemura; Toshiki Yamada; Masahito Shimizu; Takeshi Takahashi; Eiichi Tomita; Mitsuru Seishima; Tsuyoshi Takami; Hisataka Moriwaki

Book ID: 114794058
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 606 KB
Volume: 77
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2006.00702.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum-soluble Fas level determines clini

Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma

✍ Takeshi Hara; Hisashi Tsurumi; Masao Takemura; Hideko Goto; Toshiki Yamada; Mich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Serum-soluble interleukin-2 receptor (sI

Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index

✍ Hideko Goto; Hisashi Tsurumi; Masao Takemura; Yoriko Ino-Shimomura; Senji Kasaha 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 244 KB

A high serum-soluble interleukin-2 recep

A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

✍ Nozomi Niitsu; Kimiko Iijima; Aki Chizuka 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Detection of soluble interleukin-2 recep

Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure

✍ Roberto Stasi; Pier Luigi Zinzani; Piero Galieni; Vito Michele Lauta; Eugenio Da 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB